Bhagwat Singh Deora

Insider activity · 24 months3 buys2 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 1 buy · 1 saleJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 1 buy · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 1 buy · 1 saleFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€41k

Latest filing published 23 Jan 2026 for JB Chemicals & Pharmaceuticals Limited, €270k. Read the official filing

Filing timeline

BuySale

Bhagwat Singh Deora

Bhagwat Singh Deora: trading record in brief

Bhagwat Singh Deora discloses dealings in JB Chemicals & Pharmaceuticals Limited to SEBI (PIT + SAST). Over a trading history stretching from 6 December 2024 to 23 January 2026, the count stands at 7 filings.

On the market, this insider has only sold: 1 sale, €41k in total. Besides market trades, the filings include 3 share grants.

The newest entry dates from 23 January 2026: a transaction of €270k, in JB Chemicals & Pharmaceuticals Limited. Publication is fast: at least half of the trades appear on SEBI (PIT + SAST) on the same day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.